As one of the most significant developments in computing in recent years, cloud computing has become synonymous with corporate efficiency and flexibility. Industry experts are only beginning to realize the impact of cloud computing on the business environment. In this session, leading experts will discuss opportunities for growth and investment in cloud computing. Our panel will evaluate the impact of the cloud and whether it really represents a dynamic change in computing operations or a small shift in the status quo. We will examine the common risks and rewards associated with cloud computing, its impact on venture investing, and expectations for growth in the cloud business.
Moderator:
Michael R. Overly, Partner, Foley & Lardner LLP
Panelists:
Yusuf Cassim, VP Associate General Counsel, Charles Schwab
Jaye Connolly, President and Chief Executive Officer, A-Life Medical, Inc.
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.